A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening

Por Bigbee, William L., Gopalakrishnan, Vanathi, Weissfeld, Joel L., Wilson, David O., Dacic, Sanja, Lokshin, Anna E., Siegfried, Jill M.
Publicado em 2012

Increased insulin-like growth factor 1 receptor (IGF1R) protein expression and gene copy number in small cell lung cancer

Por Badzio, Andrzej, Wynes, Murry W., Dziadziuszko, Rafal, Merrick, Daniel T., Pardo, Marta, Rzyman, Witold, Kowalczyk, Anna, Singh, Shalini, Ranger-Moore, James, Manriquez, Guadalupe, Gaire, Fabien, Jassem, Jacek, Hirsch, Fred R.
Publicado em 2010

Correlation between MET Gene Copy Number by Silver in Situ Hybridization and Protein Expression by Immunohistochemistry in Non-Small-Cell Lung Cancer

Por Dziadziuszko, Rafal, Wynes, Murry W., Singh, Shalini, Asuncion, Bernadette Reyna, Ranger-Moore, James, Konopa, Krzysztof, Rzyman, Witold, Szostakiewicz, Barbara, Jassem, Jacek, Hirsch, Fred R.
Publicado em 2012

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Por Salido, Marta, Pijuan, Lara, Martínez-Avilés, Luz, Galván, Ana B., Cañadas, Israel, Rovira, Ana, Zanui, Montserrat, Martínez, Alejandro, Longarón, Raquel, Sole, Francisco, Serrano, Sergio, Bellosillo, Beatriz, Wynes, Murry W., Albanell, Joan, Hirsch, Fred R., Arriola, Edurne
Publicado em 2011

Looking Beyond Surveillance, Epidemiology, and End Results: Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population

Por Rasco, Drew W., Yan, Jingsheng, Xie, Yang, Dowell, Jonathan E., Gerber, David E.
Publicado em 2010

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Por Pataer, Apar, Kalhor, Neda, Correa, Arlene M., Raso, Maria Gabriela, Erasmus, Jeremy J., Kim, Edward S., Behrens, Carmen, Lee, J. Jack, Roth, Jack A., Stewart, David J., Vaporciyan, Ara A., Wistuba, Ignacio I., Swisher, Stephen G.
Publicado em 2012

Phase I Trial of Induction Histone Deacetylase and Proteasome Inhibition Followed by Surgery in Non-small Cell Lung Cancer

Por Jones, David R., Moskaluk, Christopher A., Gillenwater, Heidi H., Petroni, Gina R., Burks, Sandra G., Philips, Jennifer, Rehm, Patrice K., Olazagasti, Juan, Kozower, Benjamin D., Bao, Yongde
Publicado em 2012

Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

Por Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Publicado em 2012

Non-Invasive Breath Analysis of Pulmonary Nodules

Por Peled, Nir, Hakim, Meggie, Bunn, Paul A., Miller, York E., Kennedy, Timothy C, Mattei, Jane, Mitchell, John D., Hirsch, Fred R., Haick, Hossam
Publicado em 2012

A double-blind randomized discontinuation phase II study of sorafenib (BAY 43-9006) in previously treated non-small cell lung cancer patients: Eastern Cooperative Oncology Group st...

Por Wakelee, Heather A., Lee, Ju-Whei, Hanna, Nasser H., Traynor, Anne M., Carbone, David P., Schiller, Joan H.
Publicado em 2012

Pre-Diagnostic Non-steroidal Anti-inflammatory Drug Use and Lung Cancer Survival in the VITAL Study

Por Brasky, Theodore M., Baik, Christina S., Slatore, Christopher G., Alvarado, Mariela, White, Emily
Publicado em 2012

C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non-Small Cell Lung Cancer Cells with Radiation-Induced c-Met–Expression

Por Bhardwaj, Vikas, Zhan, Yanai, Cortez, Maria Angelica, Ang, K. Kian, Molkentine, David, Munshi, Anupama, Raju, Uma, Komaki, Ritsuko, Heymach, John V., Welsh, James
Publicado em 2012

A systematic analysis of efficacy of second line chemotherapy in sensitive and refractory small cell lung cancer

Por Owonikoko, Taofeek K., Behera, Madhusmita, Chen, Zhengjia, Bhimani, Chandar, Curran, Walter J., Khuri, Fadlo R., Ramalingam, Suresh S.
Publicado em 2012

High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and EGFR Mutation

Por Nunez, Maria Ines, Behrens, Carmen, Woods, Denise M., Lin, Heather, Suraokar, Milind, Kadara, Humam, Hofstetter, Wayne, Kalhor, Neda, Lee, J. Jack, Franklin, Wilbur, Stewart, David J., Wistuba, Ignacio I.
Publicado em 2012

The introduction of systematic genomic testing for patients with non-small cell lung cancer

Por Heon, Stephanie, Ortiz, Taylor M., Joshi, Victoria A., Butaney, Mohit, Jackman, David M., Kwiatkowski, David J., Yeap, Beow Y., Jänne, Pasi A., Lindeman, Neal I., Johnson, Bruce E.
Publicado em 2012

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Por Graziano, Stephen L., Gu, Lin, Wang, Xiaofei, Tatum, Arthur H., Vollmer, Robin T., Strauss, Gary M., Kratzke, Robert, Dudek, Arkadiusz Z., Vokes, Everett E, Green, Mark R.
Publicado em 2010

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene addicted non-small cell lung cancer

Por Weickhardt, Andrew J., Scheier, Benjamin, Burke, Joseph Malachy, Gan, Gregory, Lu, Xian, Bunn, Paul A., Aisner, Dara L., Gaspar, Laurie E., Kavanagh, Brian D., Doebele, Robert C., Camidge, D. Ross
Publicado em 2012

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern...

Por Horn, Leora, Bernardo, Patricia, Sandler, Alan, Wagner, Henry, Levitan, Nathan, Levitt, Mark L., Johnson, David H
Publicado em 2009

Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited stage small cell lung cancer: CALGB 30206

Por Kelley, Michael J., Bogart, Jeffrey A., Hodgson, Lydia. D., Ansari, Rafat. H., Atkins, James N., Pang, Herbert, Green, Mark R., Vokes, Everett E.
Publicado em 2013

SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2

Por Hesketh, Paul J., Chansky, Kari, Wozniak, Antoinette J., Hirsch, Fred R., Spreafico, Anna, Moon, James, Mack, Philip C., Marchello, Benjamin T., Franklin, Wilbur A., Crowley, John J., Gandara, David R.
Publicado em 2008